Bob Ingratta LifeSciences BC Konrad Sechley Gowlings Peter ...

More documents

Recommendations

Info

Patent Cooperation Treaty Chapter II – must be requested Extends proceedings to 30 months in some countries Examination carried out by Canadian Office Applicant may respond to preliminary examination Final examination report published (IPRP) Examination helpful in deciding further filing strategy May enter National phase any time during PCT 46
Where and when to file? Initial filing date Options at one year anniversary •File in CA, US, EP etc •File International (PCT) application •File in non-PCT countries Upgrade application •File in CA, US, EP etc PCT national phase 30 months from Initial filing date 47
Page 1 and 2: Bob Ingratta LifeSciences BC Konrad
Page 3 and 4: Managing Intellectual Property Pate
Page 5 and 6: Overview Introduction Bioenergy IP
Page 7 and 8: What is Intellectual Property? Asso
Page 9 and 10: Purpose of the patent system Applic
Page 11 and 12: Cons Expense - National protection
Page 13 and 14: Alternatives to Patenting Trade sec
Page 17 and 18: Eco-Patent Commons “…unleashing
Page 19: Common elements to open access sche
Page 24 and 25: Nature Biotech 24: 643-651 June 200
Page 26 and 27: Increase in US allowance rate - wil
Page 28 and 29: Statutory Subject-Matter CA EP US
Page 30 and 31: New in view of any public disclosur
Page 32 and 33: Public Disclosure (Prior Art) Made
Page 34 and 35: You have an invention - now what? C
Page 36 and 37: Who is an inventor? Person who “c
Page 38 and 39: Determining inventorship is importa
Page 40 and 41: Where and when to file? What to fil
Page 42 and 43: Provisional, informal filing - prob
Page 44 and 45: Patent Cooperation Treaty PCT appli
Page 48 and 49: Considerations Market size Cost Man
Page 50 and 51: Top tips for reducing costs 1. Dete

Bob Ingratta LifeSciences BC Konrad Sechley Gowlings Peter ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?